Clinical Trial Data on Hemoadsorption Duration for Uremic Toxin Clearance

Supplementary material from a randomized controlled trial comparing 2-hour versus 4-hour hemoadsorption combined with hemodialysis in 100 maintenance hemodialysis patients. The study, approved by an Institutional Review Board, measured clearance rates for protein-bound uremic toxins like indoxyl sulphate and parathyroid hormone. The dataset was uploaded to figshare in April 2026.

Use Cases

• Compare treatment efficacy for protein-bound uremic toxin clearance based on the described trial results.
• Analyze safety profiles of different hemoadsorption durations based on the reported adverse event rates.
• Model kinetics of specific toxins like indoxyl sulphate and hippuric acid based on the described clearance data.

Strengths

• Data originates from a randomized controlled trial with 100 patients, providing a structured experimental basis.
• Study received ethical approval from an Institutional Review Board (IRB No. [2024] No. 14).
• Results include specific statistical comparisons (P < 0.05) for multiple toxins like PTH, β2-MG, and IS.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The 85.2 KB file size suggests limited scope, likely containing supplementary documents rather than raw patient data.

Provenance

Source

figshare admin karger

Collection Method

Data collected from a randomized controlled clinical trial.

Time Range

The trial was approved in 2024; specific data collection period is not stated.

Freshness

Last updated 2026-04-15 07:55:11; freshness should be verified.

Geography

Spatial coverage is not specified in the provided metadata.